Abstract:Nitric oxide (NO) is a key signalling molecule released by vascular endothelial cells that is essential for vascular health. Low NO bioactivity is associated with cardiovascular diseases, such as hypertension, atherosclerosis, and heart failure and NO donors are a mainstay of drug treatment. However, many NO donors are associated with the development of tolerance and adverse effects, so new formulations for controlled and targeted release of NO would be advantageous. Herein, we describe the design and characterisation of a novel NO delivery system via the reaction of acidified sodium nitrite with thiol groups that had been introduced by cysteamine conjugation to porous graphene oxide nanosheets, thereby generating S-nitrosated nanosheets. An NO electrode, ozone-based chemiluminescence and electron paramagnetic resonance spectroscopy were used to measure NO released from various graphene formulations, which was sustained at >5 × 10-10 mol cm-2 min-1 for at least 3 h, compared with healthy endothelium (cf. 0.5-4 × 10-10 mol cm-2 min-1). Single cell Raman micro-spectroscopy showed that vascular endothelial and smooth muscle cells (SMCs) took up graphene nanostructures, with intracellular NO release detected via a fluorescent NO-specific probe. Functionalised graphene had a dose-dependent effect to promote proliferation in endothelial cells and to inhibit growth in SMCs, which was associated with cGMP release indicating intracellular activation of canonical NO signalling. Chemiluminescence detected negligible production of toxic N-nitrosamines. Our findings demonstrate the utility of porous graphene oxide as a NO delivery vehicle to release physiologically relevant amounts of NO in vitro, thereby highlighting the potential of these formulations as a strategy for the treatment of cardiovascular diseases.

Vitamin B3 metal-organic frameworks as potential delivery vehicles for therapeutic nitric oxide

Porous, rigid metal(III)-carboxylate metal-organic frameworks for the delivery of nitric oxide

Tuning Cellular Biological Functions Through the Controlled Release of NO from a Porous Ti-MOF

Therapeutic Potency of NO Loaded into Anticancer Copper Metal-Organic Framework through Nonclassical Hydrogen Bonding

Ultra‐Microporous Fe‐MOF with Prolonged NO Delivery in Biological Media for Therapeutic Application

Metal-organic frameworks for therapeutic gas delivery

Advances in Inorganic-Based Colloidal Nanovehicles Functionalized for Nitric Oxide Delivery.

Versatile metal-organic frameworks as a catalyst and an indicator of nitric oxide

Enhanced Oral NO Delivery through Bioinorganic Engineering of Acid-Sensitive Prodrug into a Transformer-like DNIC@MOF Microrod

S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications

An Orthoformate-Bridged Bis-diazeniumdiolates: Enhanced Nitric Oxide Loading and Released NO under Physiological Conditions

Designing Multivariate Porphyrin-Based Metal-Organic Frameworks with Ni/Co Dual-Metal Atom Sites for Cooperative NO 2 Capture and NO Retention

Metal-organic frameworks composed of nitro groups: Preparation and applications in adsorption and catalysis

Nitric Oxide (No)-Releasing Macromolecules: Rational Design and Biomedical Applications

Influence of the primary and secondary coordination spheres on nitric oxide adsorption and reactivity in cobalt(ii)-triazolate frameworks

Engineering Metal–Organic Frameworks (mofs) for Controlled Delivery of Physiological Gaseous Transmitters

Mixed Metal-Organic Framework Mixed-Matrix Membranes: Insights into Simultaneous Moisture-Triggered and Catalytic Delivery of Nitric Oxide using Cryo-scanning Electron Microscopy

Vitamin B3 Intercalated in Layered Double Hydroxides: A Drug Delivery System for Metabolic Regulation

Two New Metal-Organic Frameworks Based on Nitrogen-Containing Rigid Tetracarboxylic Acid Ligand: Synthesis, Crystal Structure, Characterization and DFT Study

Nitric oxide-triggering activity of gold-, platinum- and cerium oxide-nanozymes from S-nitrosothiols and diazeniumdiolates

Novel Ruthenium‐based Nitrosyl Complexes: NO Donation and Vasorelaxant Potentials for Cardiovascular Therapeutics